Viewing nowCombinationNewpex Duo Tablets 5mg/10mg
Atorvastatin Calcium Hydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea United Pharm., Co., Ltd.

MFDS item code 201403872 · Approved 2014.08.20 · Insurance code 644308810
Treatment of hypertension and angina; improvement of dyslipidemia; prevention of cardiovascular disease
This medication is used for patients who require treatment with both amlodipine and atorvastatin. Amlodipine is effective for treating hypertension and ischemia due to fixed obstruction of coronary arteries or vascular spasms, and it reduces the risk of hospitalization due to angina and the risk of coronary revascularization. Atorvastatin reduces the risk of several cardiovascular diseases, including myocardial infarction, stroke, and angina, and it helps treat hypercholesterolemia and dyslipidemia. In particular, it contributes to lowering the incidence of cardiovascular events in patients with various risk factors. The combined use of these two medications effectively improves cardiovascular health.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, amlodipine and atorvastatin. Amlodipine (S-amlodipine) Adults: Administer 5(2.5) mg of amlodipine (S-amlodipine) orally once daily; the dose may be increased to a maximum of 10(5) mg daily according to the patient's response. Adjust the dose as appropriate according to symptoms. Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. It may be taken at any time of day, with or without food. 1. Patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and combined (mixed) dyslipidemia (Fredrickson Type Ⅱa and Ⅱb) The recommended initial dose of this medicine is 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only for patients requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered at a dose of 10 mg ∼ 80 mg once daily and may be taken at any time of day, with or without food. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ∼ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. 2. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 mg ∼ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. 3. Patients with renal impairment Renal disease does not affect the plasma concentration of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dose adjustment is necessary. 4. Elderly patients The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
This medication should not be used in certain patients. For example, patients with allergies to this medication or similar drugs, severely impaired liver function, active liver diseases, pregnant women or women who may become pregnant, breastfeeding women, patients with muscular diseases, patients with severe aortic stenosis, patients in shock, patients within one month after a myocardial infarction, patients with unstable angina, and patients taking specific antiviral agents should not be administered this medication. Moreover, patients with severely impaired renal function, elderly individuals, patients with a history of alcohol abuse or liver diseases, patients at high risk for muscle damage, patients with acute heart failure, patients in hypertensive crisis, patients with mild to moderate liver dysfunction, and patients with severe myasthenia gravis should use this medication cautiously. This medication is primarily composed of two ingredients and is generally well tolerated, but some patients may experience symptoms such as flushing due to vasodilation, fatigue, edema, palpitations, dizziness, headache, drowsiness, abdominal pain, and nausea. Additionally, rare side effects such as myalgia, muscle cramps, hepatic dysfunction, allergic reactions, skin rashes, hair loss, insomnia, and coughing have been reported. One of the components of this medication is metabolized in the liver, so patients with impaired liver function require regular liver function tests, and the medication should be discontinued if any liver dysfunction is detected. Moreover, if muscle-related abnormal symptoms appear, the physician should be notified immediately, and if severe muscle pain or muscle weakness occurs, the medication should be stopped. This medication may interact with other drugs, particularly certain antibiotics, antifungals, immunosuppressants, some antivirals, and grapefruit juice, requiring caution when used concurrently. Pregnant or breastfeeding women should not take this medication, and women of childbearing potential should use appropriate contraception while taking this medication. The safety in pediatric and elderly populations has not been sufficiently confirmed, so caution is needed in these groups. In case of overdose, symptoms such as decreased blood pressure and cardiac dysfunction may appear, necessitating immediate medical attention. This medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best kept in a cool place between 15 and 30 degrees Celsius. This way, the effectiveness of the medication can be well maintained.
White oval film-coated tablet
For Domestic Use: 30 tablets/bottle For Export: 30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium Hydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea United Pharm., Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Viatriss Korea Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 21.7mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Viatrise Korea Co., Ltd.
CombinationAtorvastatin Calcium Trihydrate 43.4mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Viatris Korea Co., Ltd.
CombinationAtorvastatin Calcium Hydrate 10.85mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Atorvastatin Calcium Trihydrate 10.36mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationAtorvastatin Calcium 20.72mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
CombinationAtorvastatin Calcium 10.36mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.